OptiNose Corp (OPTN): Bagan tingkat prakiraan

Logo korporat perusahaan OptiNose Inc (OPTN)

This daily price chart for OptiNose, Inc. (OPTN) on the GURU.Markets platform captured the value 9.01. The business relies on external contractors for manufacturing and testing, prioritizing promotion. The company is currently scaling sales of XHANCE for the treatment of rhinosinusitis, utilizing automated assembly lines for the precision manufacturing of drug delivery system components.

OPTN - Bagan rega target OptiNose Inc ing rentang 04.07.2022 - 31.05.2025

Rincian analitis perusahaan Optinose (OPTN)

OPTN — sistem indikator bursa lan keuangan OptiNose Corp:
Analisis umum perusahaan:OPTN optinose.com
Barang unggulan OptiNose Corp

The investment attractiveness of OptiNose, Inc. (OPTN) is determined through the discounting of future cash flows, where fundamental value depends on the market share of innovative spray systems. The weighted average target from investment houses aggregates analysts' capitalization expectations, reflecting the impact of patent protection and lengthy regulatory approval timelines for devices on the fair value of the stock.

Pesaing OptiNose, Inc.

HLN - Rata-rata rega prakiraan|Bagan rega target Kenvue KVUE|VRNA (Verona Pharma PLC) - Bagan tingkat prakiraan|MENS: Target konsensus|Ligand Corp - Rega prakiraan analis|Amneal Pharmaceuticals (AMRX) - Bagan rega target|Prakiraan gabungan firma investasi PRGO|Bagan rega target Alvotech SA|Liquidia Corp - Bagan tingkat prakiraan|Prakiraan konsensus analis GLPG|ANIP (ANI Pharmaceuticals Corp) - Konsensus nilai wajar|Prakiraan konsensus analis MNKD (MannKind Corporation)|Prakiraan konsensus analis amphastar.com AMPH|PCRX - Bagan rega target|Konsensus nilai wajar SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Bagan rega target|Target konsensus Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Prakiraan konsensus analis|Prakiraan konsensus analis Tectonic|Target konsensus TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Konsensus nilai wajar|Bagan rega target Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Rata-rata rega prakiraan|EXOZ: Target konsensus|Oramed Pharmaceuticals - Rega prakiraan analis|ENTX: Prakiraan konsensus analis|MindWalk Holdings, Inc. - Konsensus nilai wajar|ABVC (ABVC BioPharma Inc) - Prakiraan konsensus analis|Rata-rata rega prakiraan Cumberland Corp CPIX|Bagan rega target Quantum BioPharma Ltd (QNTM)|FGEN (fibrogen.com) - Konsensus nilai wajar|Bagan rega target Telomir Pharmaceuticals, Inc. TELO|Rani Therapeutics Holdings (RANI) - Rata-rata rega prakiraan|SNYR - Bagan rega target|Bagan tingkat prakiraan RLYB|LEXX (lexariabioscience.com) - Target konsensus|PULM: Rega prakiraan analis|PTHL (Pheton Holdings Limited) - Prakiraan konsensus analis|Aptorum (APM) - Target median analis|Bagan rega target Lyra Therapeutics, Inc (LYRA)|impactbiomedinc.com - Prakiraan gabungan firma investasi|Bagan rega target TNF Pharmaceuticals, Inc. TNFA|cbdMD Inc. (YCBD) - Rata-rata rega prakiraan|PRFX - Bagan rega target|Target median analis Altamira Therapeutics CYTO|LIPO: Prakiraan konsensus analis|Rata-rata rega prakiraan Pieris Pharma (PIRS)|Target konsensus PROC|PTPI: Konsensus nilai wajar|Prakiraan konsensus analis QLI|Target median analis Acelyrin Inc.|Bagan rega target TFF Pharma TFFP